Breast Cancer Index predicts extended endocrine benefit to individualize selection of HR+ early stage breast cancer patients for 10 years of endocrine therapy
Noordhoek, Iris, Treuner, Kai, Putter, Hein, Zhang, Yi, Wong, Jenna, Meershoek - Klein Kranenbarg, Elma, Duijm-de Carpentier, Marjolijn, van de Velde, Cornelis J.H., Schnabel, Catherine A, Liefers, GeJournal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-20-2737
Date:
October, 2020
Fichier:
PDF, 1.13 MB
2020
File converter
Plus de résultats de recherche
More benefits 
